SP
ABBV icon

Stonebrook Private’s AbbVie ABBV Stock Holding History

Stonebrook Private’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Sell
8,522
-342
-4% -$73.6K 0.39% 54
2026
Q1 		$1.93M Sell
8,864
-180
-2% -$39.9K 0.41% 55
2025
Q4 		$2.07M Sell
9,044
-8,844
-49% -$2.01M 0.43% 49
2025
Q3 		$4.14M Buy
17,888
+521
+3% +$106K 0.89% 30
2025
Q2 		$3.22M Buy
17,367
+13,817
+389% +$2.57M 0.75% 31
2025
Q1 		$744K Buy
3,550
+278
+8% +$54K 0.19% 101
2024
Q4 		$581K Buy
3,272
+200
+7% +$36.8K 0.15% 107
2024
Q3 		$607K Buy
3,072
+134
+5% +$25K 0.16% 109
2024
Q2 		$504K Buy
2,938
+153
+5% +$25.3K 0.14% 117
2024
Q1 		$507K Buy
2,785
+156
+6% +$26.9K 0.15% 117
2023
Q4 		$407K Buy
+2,629
New +$383K 0.14% 132

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stonebrook Private's ABBV Position: Q2 2026 in Review

Stonebrook Private reduced its AbbVie (ABBV) stake by 3.9% in Q2 2026, selling an estimated $73.6K and leaving 8,522 shares worth $2.14M. The position accounts for 0.39% of the portfolio, ranked #54.

Stonebrook Private first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.14M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stonebrook Private held 8,522 shares of AbbVie worth $2.14M as of Q2 2026.
  • Stonebrook Private sold 342 AbbVie shares in Q2 2026, an estimated $73.6K.
  • AbbVie made up 0.39% of Stonebrook Private's portfolio in Q2 2026, its #54 holding.
  • Stonebrook Private first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Stonebrook Private's AbbVie position peaked at $4.14M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.